Article Text

other Versions

PDF
Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion
  1. Hidetaka Noma1,
  2. Hideharu Funatsu1,
  3. Tatsuya Mimura2,
  4. Shuichiro Eguchi3,
  5. Katsunori Shimada4
  1. 1Department of Ophthalmology, Yachiyo Medical Center, Tokyo Women's Medical University, Chiba, Japan
  2. 2Department of Ophthalmology, University of Tokyo Graduate School of Medicine, Tokyo, Japan
  3. 3Department of Ophthalmology, Eguchi Eye Hospital, Hakodate, Japan
  4. 4Department of Hygiene and Public Health II, Tokyo Women's Medical University, Tokyo, Japan
  1. Correspondence to Hidetaka Noma, Department of Ophthalmology, Yachiyo Medical Center, Tokyo Women's Medical University, 477-96, Owada-shinden, Yachiyo, Chiba 276-8524, Japan; nomahide{at}tymc.twmu.ac.jp

Abstract

Background and aims To measure soluble vascular endothelial growth factor receptor-2 (sVEGFR-2) in the vitreous fluid of patients with central retinal vein occlusion (CRVO) and macular oedema or patients with idiopathic macular hole, and to investigate the relation between sVEGFR-2 and vascular endothelial growth factor (VEGF).

Methods Vitreous fluid samples were obtained from 44 patients during vitreoretinal surgery (29 patients with CRVO and 15 with macular hole). Then the sVEGFR-2 and VEGF levels were measured by ELISA. Retinal ischaemia was evaluated by measuring the area of capillary nonperfusion on fluorescein angiograms with the public domain Scion Image program. Macular oedema was examined by optical coherence tomography.

Results CRVO patients had significantly higher vitreous levels of sVEGFR-2 (median (IQR): 1200 pg/ml (835–1740)) than macular hole patients (945 pg/ml (691–1292), p=0.042)). They also had significantly higher vitreous VEGF levels (324 pg/ml (114–1218) vs 15.6 pg/ml (15.6–15.6), p<0.001). In CRVO patients, the vitreous level of VEGF was significantly correlated with the severity of macular oedema (ρ=0.50, p=0.008), but the sVEGFR-2 level was not. The product (sVEGFR-2×VEGF) was also significantly correlated with the severity of macular oedema (ρ=0.49, p=0.008). The strength of the association with macular oedema was similar for the product (sVEGFR-2×VEGF) and for VEGF alone.

Conclusion These findings suggest that macular oedema in CRVO patients is more closely related to VEGF than sVEGFR-2.

  • Soluble vascular endothelial growth factor receptor-2
  • vascular endothelial growth factor
  • macular oedema
  • central retinal vein occlusion
  • macula
  • medical education

Statistics from Altmetric.com

Footnotes

  • Competing interests None declared.

  • Ethics approval This study was conducted with the approval of the Tokyo Women's Medical University and Eguchi Eye Hospital.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles